Boehringer Ingelheim Pharma GmbH &co KG

Boehringer Ingelheim Pharma GmbH &co KG is a company in Ingelheim, Germany that has taken part in 22 EU-funded projects since 2009, receiving €1.9M in EU funding.

EU funding received€1.9M
EU projects22
As coordinator0
Running now10
First EU project2009
Latest project2026
CountryGermany
EU registration (PIC)994623839
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Boehringer Ingelheim Pharma GmbH &co KG's own share of each project, not the project's full budget.

  • Horizon 2020€969k · 7 projects
  • FP7 (2007 to 2013)€619k · 5 projects
  • Horizon Europe€290k · 10 projects

Projects

22 EU-funded projects, newest first. Each links to the official record.

  • PANDORAAssociated partner

    Doctoral network on discovering pathomechanisms and novel drug optimization for AMD

    Horizon Europe · 2026–2030 · Project on CORDIS ↗

  • PFAROSAssociated partner

    Driving Sustainable Innovation to Minimise PFAS in European Healthcare

    Horizon Europe · 2026–2031 · Project on CORDIS ↗

  • FORTIFYAssociated partner

    FORTIFY - FRAMEWORK FOR OPTIMIZED REGULATION, TRADE SECRETS, AND INTELLECTUAL PROPERTY IN A FEDERATED EUROPEAN HEALTH DATA SPACE

    Horizon Europe · 2026–2029 · Project on CORDIS ↗

  • LipidBRIGHTAssociated partner

    Lipids as promising BRidge between novel disease InsiGHts and improved Therapy

    Horizon Europe · 2026–2030 · Project on CORDIS ↗

  • WATERPartner

    Doctoral Network on Interfacial Water in Membrane Transport

    Horizon Europe · 2025–2029 · Project on CORDIS ↗

    €290ktheir share
  • RealiseDAssociated partner

    Comprehensive methodological and operational approach to clinical trials in rare and ultra-rare diseases

    Horizon Europe · 2025–2029 · Project on CORDIS ↗

  • ENKOREAssociated partner

    Propelling the shift toward the future of circular, safe and sustainable packaging and single use device ecoDesigned solutions through healthcare environments

    Horizon Europe · 2025–2028 · Project on CORDIS ↗

  • PharmEcoAssociated partner

    Advancing Safe and Sustainable by design Practices in Pharmaceutical Manufacturing

    Horizon Europe · 2024–2030 · Project on CORDIS ↗

  • NHPigAssociated partner

    Reducing Non-Human Primates in Non-Clinical Safety Assessment: The European Initiative on Minipig and Micropig Models

    Horizon Europe · 2024–2029 · Project on CORDIS ↗

  • VICT3RAssociated partner

    Developing and implementing VIrtual Control groups To reducE animal use in toxicology Research

    Horizon Europe · 2024–2028 · Project on CORDIS ↗

  • INSPIREPartner

    INnovation in Safety Pharmacology for Integrated cardiovascular safety assessment to REduce adverse events and late stage drug attrition.

    Horizon 2020 · 2020–2024 · Project on CORDIS ↗

    €253ktheir share
  • PROTONPartner

    Proton transport and proton-coupled transport

    Horizon 2020 · 2019–2024 · Project on CORDIS ↗

    €253ktheir share
  • ENTRAINPartner

    ENdoThelial macRophage Alliance In Neuroinflammation

    Horizon 2020 · 2019–2023 · Project on CORDIS ↗

  • TICARDIOPartner

    Thrombo-inflammation in cardiovascular disease

    Horizon 2020 · 2019–2023 · Project on CORDIS ↗

  • EUROoCPartner

    Interdisciplinary training network for advancing Organ-on-a-chip technology in Europe

    Horizon 2020 · 2018–2023 · Project on CORDIS ↗

  • BIGCHEMPartner

    Big Data in Chemistry

    Horizon 2020 · 2016–2019 · Project on CORDIS ↗

    €464ktheir share
  • eCHO SystemsPartner

    Enhancing CHO by Mammalian Systems Biotechnology (eCHO systems)

    Horizon 2020 · 2015–2018 · Project on CORDIS ↗

  • DISCOPartner

    From DISCOvery to products: A next generation pipeline for the sustainable generation of high-value plant products

    FP7 (2007 to 2013) · 2013–2017 · Project on CORDIS ↗

    €48ktheir share
  • TS-EUROTRAINPartner

    Interdisciplinary training network for Tourette Syndrome; structuring European Training capacities for neurodevelopmental disorders

    FP7 (2007 to 2013) · 2012–2016 · Project on CORDIS ↗

    €249ktheir share
  • ALEXANDERPartner

    Mucus Permeating Nanoparticulate Drug Delivery Systems

    FP7 (2007 to 2013) · 2012–2016 · Project on CORDIS ↗

    €116ktheir share
  • TRANSPOLPartner

    Transport and signalling in Polarized Cells

    FP7 (2007 to 2013) · 2010–2014 · Project on CORDIS ↗

  • NEURASYNCPartner

    Academic-Industrial Training Network on Alpha-Synuclein-related Brain Diseases

    FP7 (2007 to 2013) · 2009–2013 · Project on CORDIS ↗

    €206ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • RNA
  • alzheimer
  • animal and dairy science
  • arteriosclerosis
  • artificial intelligence
  • big data
  • biofuels
  • biophysics
  • cardiovascular diseases
  • cell biology
  • chemical sciences
  • civil society
  • colors
  • computational intelligence

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime